These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 1723682

  • 1. The 'Sicilian Gambit'. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Eur Heart J; 1991 Oct; 12(10):1112-31. PubMed ID: 1723682
    [Abstract] [Full Text] [Related]

  • 2. The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Circulation; 1991 Oct; 84(4):1831-51. PubMed ID: 1717173
    [Abstract] [Full Text] [Related]

  • 3. Antiarrhythmic drug classifications and the clinician: a gambit in the land of chaos.
    Katritsis D, Camm AJ.
    Clin Cardiol; 1994 Mar; 17(3):142-8. PubMed ID: 7513270
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Profiles of aprindine, cibenzoline, pilsicainide and pirmenol in the framework of the Sicilian Gambit. The Guideline Committee for Clinical Use of Antiarrhythmic Drugs in Japan (Working Group of Arrhythmias of the Japanese Society of Electrocardiology).
    Kodama I, Ogawa S, Inoue H, Kasanuki H, Kato T, Mitamura H, Hiraoka M, Sugimoto T.
    Jpn Circ J; 1999 Jan; 63(1):1-12. PubMed ID: 10084381
    [Abstract] [Full Text] [Related]

  • 14. [Classification and mechanism of action of anti-arrhythmia drugs].
    Gasic S.
    Wien Med Wochenschr; 1994 Jan; 144(14-15):338-42. PubMed ID: 7825324
    [Abstract] [Full Text] [Related]

  • 15. Is there a need for new antiarrhythmic drugs?
    Roden DM.
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
    [Abstract] [Full Text] [Related]

  • 16. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A, Starmer CF, Bezerianos A.
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S, Duker G, Carlsson L.
    Prog Biophys Mol Biol; 2008 Feb; 98(2-3):328-39. PubMed ID: 19038282
    [Abstract] [Full Text] [Related]

  • 20. Pharmacotherapy of cardiac arrhythmias--basic science for clinicians.
    Shu J, Zhou J, Patel C, Yan GX.
    Pacing Clin Electrophysiol; 2009 Nov; 32(11):1454-65. PubMed ID: 19744278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.